Brain Circuitry & Chronic Pain: New Insights into Treatment & Relief

For the roughly 50 million Americans living with chronic pain, a condition where pain persists long after an initial injury has healed, a new understanding of how the brain processes pain offers a potential pathway toward more effective treatments. Researchers at the University of Pennsylvania, collaborating with colleagues at the University of Pittsburgh and Scripps Research Institute, have identified a specific group of brainstem cells that appear to act as a “switch” for chronic pain, offering a target for future therapies.

The discovery, published in the journal Nature, centers on neurons expressing the Y1 receptor (Y1R) located in the lateral parabrachial nucleus (lPBN) of the brainstem. These neurons aren’t solely dedicated to pain processing; they as well respond to signals related to fundamental survival needs like hunger, fear and thirst. This suggests the brain prioritizes these urgent needs, and can modulate pain responses accordingly. The research builds on the understanding that chronic pain isn’t simply an ongoing injury signal, but a fundamentally altered state within the central nervous system.

Tracking Pain’s Signal in the Brain

The team, led by neuroscientist J. Nicholas Betley at the University of Pennsylvania, used calcium imaging to observe neuron activity in animal models experiencing both acute and chronic pain. They found that while Y1R neurons reacted predictably to short bursts of pain, they exhibited sustained, or “tonic,” activity during prolonged pain states. Betley likened this to an engine idling after a car has been parked – the pain signal continues even when the initial cause is no longer present. This ongoing neural activity may explain why pain can linger long after physical healing is complete.

This finding emerged from an intriguing observation Betley made upon joining Penn in 2015: he noticed that hunger seemed to lessen chronic pain. “From my own experience, I felt that when you’re really hungry you’ll do almost anything to get food,” he explained. “When it came to chronic, lingering pain, hunger seemed to be more powerful than Advil at reducing pain.” This personal observation sparked a deeper investigation into how the brain prioritizes survival needs over persistent pain.

Further research, led by former graduate student Nitsan Goldstein, revealed that other critical survival states – thirst and fear – could also suppress long-term pain. In collaboration with the Kennedy lab at Scripps Research, the team demonstrated that the parabrachial nucleus can filter sensory input, effectively quieting pain signals when immediate survival is at stake. This led them to believe the brain possesses an inherent mechanism for overriding pain when more pressing needs demand attention.

The Role of Neuropeptide Y

A key component of this “override switch” is neuropeptide Y (NPY), a signaling molecule that helps the brain balance competing needs. When hunger or fear takes precedence, NPY acts on Y1 receptors in the parabrachial nucleus, dampening the ongoing pain signals. Goldstein explained it as a built-in system: “If you’re starving or facing a predator, you can’t afford to be overwhelmed by lingering pain. Neurons activated by these other threats release NPY, and NPY quiets the pain signal so that other survival needs take precedence.”

The researchers also investigated the physical arrangement of Y1R neurons within the lPBN. Surprisingly, they didn’t identify a distinct, localized cluster of these neurons. Instead, Y1R expression was scattered across various other cell types, resembling “yellow paint distributed across red cars, blue cars, and green cars,” as Betley described it. The purpose of this mosaic distribution remains unclear, but the researchers hypothesize it may allow the brain to modulate different types of painful inputs across multiple circuits.

Implications for Chronic Pain Treatment

Betley believes this discovery opens the door to using Y1 neural activity as a biomarker for chronic pain – a tool clinicians and drug developers have long lacked. Currently, patients often receive a diagnosis of chronic pain without a clear underlying injury. “What we’re showing is that the problem may not be in the nerves at the site of injury, but in the brain circuit itself,” Betley stated. “If we can target these neurons, that opens up a whole new path for treatment.”

This research also suggests that behavioral interventions, such as exercise, meditation, and cognitive behavioral therapy, may influence the activity of these brain circuits, mirroring the effects observed with hunger, and fear. As Betley noted, “We’ve shown that this circuit is flexible, it can be dialed up or down. So, the future isn’t just about designing a pill. It’s also about asking how behavior, training, and lifestyle can change the way these neurons encode pain.”

Chronic pain is often described as a central nervous system disorder, meaning the problem lies within the brain and spinal cord rather than at the site of the initial injury. Research published in the International Journal of Molecular Sciences highlights how multi-network activation in the CNS contributes to the sensory, emotional, cognitive, and behavioral components of chronic pain. This understanding is crucial for developing effective treatment strategies.

Central Sensitization and the Nervous System

The concept of central sensitization is central to understanding chronic pain. As explained by Advanced MMC, this occurs when the central nervous system becomes overly responsive, leading to even gentle touch being perceived as painful. This hypersensitivity can develop when nerves are repeatedly stimulated, causing physical changes in the nervous system. This process is also described in detail by The Merck Manual, which notes that repeated stimulation can alter the structure and activity of nerve fibers and cells.

What comes next involves further research to fully understand the complex interplay of neurons within the lPBN and how they contribute to chronic pain. Researchers will likely focus on developing targeted therapies that modulate Y1R activity, as well as exploring the potential of behavioral interventions to influence these brain circuits. Clinical trials will be essential to determine the safety and efficacy of any new treatments. The development of reliable biomarkers, such as those based on Y1 neural activity, will also be crucial for diagnosing and monitoring chronic pain.